Supplement Amino Acid
Information source: Pennington Biomedical Research Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Growth Hormone; Amino Acid
Intervention: Amino acid supplement (Drug); Placebo (Drug)
Phase: N/A
Status: Completed
Sponsored by: Pennington Biomedical Research Center
Summary
The purpose of the study is to confirm the results of a prior study that demonstrated pills
containing two amino acids which are in foods increased growth hormone and insulin-like
growth factor-1.
Clinical Details
Official title: Growth Hormone 120 Minutes Following a Single Low-dose of Amino Acids in Healthy Subjects.
Study design: Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science
Primary outcome: Quantity of Growth Hormone
Secondary outcome: Insulin-like growth factor 1
Detailed description:
Oral supplementation with a key combination of derivatives that has been shown to increase
human growth hormone in healthy volunteers peaking at 90 minutes and IGF-1 at 8 hours
post-administration.
Eligibility
Minimum age: 18 Years.
Maximum age: 70 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- 12 healthy males and 4 healthy females
- Between 18 and 70 years
Exclusion Criteria:
- Pregnant or nursing
- Taking any chronic medication including birth control pills.
Locations and Contacts
Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808, United States
Additional Information
Starting date: October 2011
Last updated: June 6, 2014
|
